Study finds children with residual amblyopia did not find an advantage with levodopa

Article

A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.

Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA. 

 

Read the results of the study here.

Recent Videos
Ben Casella, OD, FAAO, giving a reminder for eye care providers to register for EyeCon 2024.
Dr. Brian Lojka chats about strabismus in athletes
Jack Chapman, MD, talks best candidates for light adjustable lenses.
Diabetic eye care expert A. Paul Chous, OD, MA, FAAO, shares insights on patient care and research
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.